MindWalk Holdings (HYFT) Short term Debt (2020 - 2025)
MindWalk Holdings (HYFT) posted quarterly Short term Debt of $220656.8 for Q2 2025, up 5.35% year-over-year from $209455.8 in Q2 2024, and up 5.12% quarter-over-quarter from $209919.2 in Q1 2025.
MindWalk Holdings (HYFT) Short term Debt (2020 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has reported Short term Debt for 6 consecutive years, with $220656.8 the latest figure, recorded in Q2 2025.
- In Q2 2025, Short term Debt rose 5.35% year-over-year to $220656.8; the TTM figure through Apr 2025 stood at $220656.8 (up 5.35% YoY), while the FY2025 annual figure was $225416.6, up 7.12% from the prior year.
- Short term Debt climbed to $220656.8 in Q2 2025 per HYFT's latest filing, from $209919.2 in the prior quarter.
- Across five years, Short term Debt topped out at $1.9 million in Q3 2024 and bottomed at $209455.8 in Q2 2024.
- Historically, Short term Debt has averaged $457207.6 across 5 years, with a median of $324442.6 in 2023.
- Annual changes were most pronounced in 2023 — Short term Debt sank 64.75% — and 2024, when it jumped 788.93%.
- MindWalk Holdings' Short term Debt stood at $395560.2 in 2021, then fell by 5.4% to $374189.0 in 2022, then tumbled by 42.65% to $214610.7 in 2023, then advanced by 1.68% to $218222.0 in 2024, then climbed by 1.12% to $220656.8 in 2025.
- Business Quant data shows HYFT's Short term Debt at $220656.8 in Q2 2025, $209919.2 in Q1 2025, and $218222.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 220,656.81 |
| Jan 31, 2025 | 209,919.20 |
| Oct 31, 2024 | 218,222.03 |
| Jul 31, 2024 | 1.90 Mn |
| Apr 30, 2024 | 209,455.76 |
| Jan 31, 2024 | 213,779.51 |
| Oct 31, 2023 | 214,610.72 |
| Jul 31, 2023 | 213,523.08 |
| Apr 30, 2023 | 324,442.59 |
| Jan 31, 2023 | 395,904.62 |
| Oct 31, 2022 | 374,189.03 |
| Jul 31, 2022 | 605,693.63 |
| Apr 30, 2022 | 584,270.80 |
| Apr 30, 2021 | 395,560.17 |
| Jan 31, 2021 | 779,804.73 |
| Oct 31, 2020 | 5,313.97 |
| Apr 30, 2020 | 138,281.62 |